Vanberra Signal
Kerys logo

Kerys

Curated by Signal

Loan origination solutions optimizing lending processes for financial institutions.

Overview

Kerys is a company that focuses on loan origination solutions for banks and financial institutions. It offers software designed to improve the initial stages of the lending process. The company employs artificial intelligence to assist in application assessments, automate decision-making, and customize loan terms. Kerys also incorporates blockchain technology to enhance security and transparency, while utilizing big data analytics for predictive risk assessments and customized loan offerings. The primary audience for Kerys includes businesses, professionals, and financial institutions that aim to streamline financial processes. Additionally, Kerys provides a suite of digital tools, including the SaaS platform Forekasts, to help clients manage financial development stages and maintain regulatory compliance.

Key facts

Founded
2020
Headquarters
Montreuil, France

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Banking Technology companies
  • Loan origination solutions optimizing financial processes for banks and institutions.

    Banking TechnologySan Pedro Garza Garcia, Mexico
  • Loan origination solutions enhancing lending processes for financial institutions.

    Banking TechnologyMalvern, United States
  • Loan origination solutions enhancing efficiency and compliance for banks.

    Banking TechnologyMontreal, Canada
+ 68 more similar companies on Signal

About Kerys

What does Kerys do?

Kerys is a company that focuses on loan origination solutions for banks and financial institutions.

Where is Kerys headquartered?

Kerys is headquartered in Montreuil, France.

When was Kerys founded?

Kerys was founded in 2020.

Which sector is Kerys in?

Kerys operates in Banking Technology, part of Financial Technology.

Who are Kerys's competitors?

Companies similar to Kerys include Acendes, Anovaa, and BusinessBANKER.